Uphealth Inc (UPH) Financials

$0.38

$0.03 (9.94%)

As on 13-Feb-2024 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$153 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	153.15	158.80	123.80	5.40	--	--
Cost of Revenue	74.66	88.65	80.21	1.18	--	--
Gross Profit	78.49	70.16	43.59	4.21	--	--
Operating Expenses	77.11	95.20	88.43	6.14	--	--
Operating Profit (EBIT)	-84.86	-25.04	-44.85	-1.93	-0.95	--
Other Income	--	--	56.16	1.02	--	--
Profit before Tax	-64.35	-232.32	-342.77	-2.06	0.85	--
Provision for Tax	10.14	-9.38	-2.44	0.05	--	--
Profit after Tax (Net Income)	-75.00	-222.94	-340.34	-2.11	0.30	--
Minority Interest	-1.60	-0.07	0.13	--	--	--
Consolidated Profit	-54.57	-223.00	-341.02	-4.68	-0.71	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	64.13	105.15	318.46	220.72	175.25	--
Minority Interest	-1.60	--	15.38	--	--	--
Non-Current Liabilities	4.65	164.79	138.76	6.80	--	--
Current Liabilities	166.37	68.88	96.70	34.87	0.34	--
Total Liabilities	401.51	339.80	569.31	262.39	173.99	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	213.14	296.48	462.56	249.70	--	--
Current Assets	22.01	43.32	106.75	12.69	173.99	--
Total Assets	401.51	339.80	569.31	262.39	173.99	--
Total Debt*	150.85	157.48	121.50	23.30	--	--
Net Current Assets	-144.36	-25.65	10.04	-22.18	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-24.14	-62.82	-1.14	-1.48	--
Cash Flow from Investing Activities	--	-13.33	0.74	6.63	-172.12	--
Cash from Financing Activities	--	-23.32	135.87	-5.67	175.18	--
Net Cash Inflow / Outflow	--	--	73.80	-1.10	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-63.46	-99.52	-1.01	--	--
ROE (%)	-92.10	-105.25	-126.24	-1.06	--	--
ROA (%)	-18.44	-49.04	-81.84	-0.97	--	--
EBIT Margin (%)	1.26	-15.77	-36.23	-35.69	--	--
Net Margin (%)	-48.97	-140.38	-189.12	-32.83	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	4.70	0.28	21.94	--	--	--
EBIT Growth (%)	102.11	44.16	-2,228.40	--	--	--
Net Profit Growth (%)	3.94	34.50	-16,052.63	-813.95	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.07	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.79	-54.88	-2.35	91.72	--	--
Close Price ($)	0.98	1.63	22.40	109.50	99.50	--
High Price ($)	5.90	27.87	116.40	121.20	100.00	--
Low Price ($)	0.96	1.61	16.10	96.00	96.80	--
Market Cap ($ Cr)	5.33	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	1.50	0.38	0.11	--	--
Short term debt to equity ratio	2.30	0.05	0.07	0.10	--	--
Current Ratio	0.13	0.63	1.10	0.36	511.81	--
Quick Ratio	0.13	0.63	1.07	0.36	--	--
Interest Coverage	-1.39	-0.95	-2.30	-14.37	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	10.79	13.77	18.42	124.22	--	--
Asset Turnover	0.38	0.35	0.30	0.02	--	--
Receivable days	--	51.37	43.52	453.72	--	--
Inventory Days	--	6.36	6.93	36.12	--	--
Payable days	--	65.07	37.08	827.45	--	--
Cash Conversion Cycle	--	-7.34	13.38	-337.60	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.